Assessment of contribution of BCRP to intestinal absorption of various drugs using portal‐systemic blood concentration difference model in mice-Reference-Cited by-同舟云学术

Assessment of contribution of BCRP to intestinal absorption of various drugs using portal‐systemic blood concentration difference model in mice

Published:2020-01-17 Issue:1 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Kawahara Iichiro¹,Nishikawa Satoyo¹,Yamamoto Akira¹,Kono Yusuke²,Fujita Takuya²^ORCID

Affiliation:

1. Department of Biopharmaceutics Kyoto Pharmaceutical University Kyoto Japan

2. Graduate School of Pharmaceutical Sciences Ritsumeikan University Shiga Japan

Funder

Ritsumeikan University

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.544

Reference35 articles.

1. Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines

2. Correlation of gene expression of ten drug efflux proteins of the ATP‐binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco‐2 cell monolayer;Taipalensuu J;J Pharmacol Exp Ther,2001

3. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization

4. Characterization of Polarized Expression of Point- or Deletion-Mutated Human BCRP/ABCG2 in LLC-PK1 Cells

5. Nonlinear partial differential equations and applications: The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probe substrates assay estimates the effect of polyphyllin H on the activity of cytochrome P450 enzymes in human liver microsomes;Pharmacology Research & Perspectives;2024-08-29

2. Natural agents' role in cancer chemo-resistance prevention and treatment: molecular mechanisms and therapeutic prospects;PHARM PRACT-GRANADA;2024

3. Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy;International Journal of Molecular Sciences;2023-08-23

4. Association ofSTAT3, CYP3A5, andABCG2Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients;Anticancer Research;2023-03-27

5. Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter;Poultry Science;2023-01